TYROBP and cancer: Firstly, we found that the expressional level of TYROBP was significantly (adjusted p < 0.05) lower in cancers including READ, PAAD, LUAD, LUSC, COAD, and OS, while the expressional level was higher in cancers including THCA, BRCA, STAD, ESCA, and GBM (Fig. 4A).